Where Tomorrow’s Discoveries Begin

GLP-1 agonists like semaglutide and tirzepatide are transforming the management of obesity and type 2 diabetes. This article examines their mechanisms, benefits, risks, and the profound implications for public health.

## Introduction In recent years, a new class of medications has taken the health world by storm, promising not just better control of diabetes but also unprecedented results in weight management. At the forefront is sem…